Vioxx Rulings Could Bode Ill For N.J. Class Actions

Law360, New York (June 10, 2008, 12:00 AM EDT) -- In two recent Vioxx-related decisions, New Jersey appellate courts have further defined and reduced the scope of product liability actions by precluding: (1) medical monitoring in the absence of present injury, (2) consumer fraud claims, and (3) punitive damages.

In Sinclair v. Merck & Co. Inc., No. A-117-06 (N.J. June 4, 2008), the New Jersey Supreme Court affirmed the trial court's dismissal of a putative product liability class action seeking to recover the costs of medical monitoring of alleged silent or latent cardiovascular injury from ingestion...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.